[
    [
        {
            "time": "2018-07-01",
            "original_text": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点關注稳健增長和“流量入口”型公司",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报业绩",
                    "医疗需求",
                    "刚性",
                    "稳健增长",
                    "流量入口"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点關注稳健增長和“流量入口”型公司",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-15",
            "original_text": "[买入评级]医药生物行业7月月报：调整中布局下半年行情",
            "features": {
                "keywords": [
                    "医药生物",
                    "7月月报",
                    "调整",
                    "布局",
                    "下半年行情"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[买入评级]医药生物行业7月月报：调整中布局下半年行情",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-30",
            "original_text": "[推荐评级]医药生物行业2018年中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报业绩",
                    "重点覆盖",
                    "2季度",
                    "增速加快",
                    "个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业2018年中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]